Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Yamamoto

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 25, 2009
Pharmacokinetics of 5-fluorouracil in elderly Japanese patients with cancer treated with S-1 (a combination of tegafur and dihydropyrimidine dehydrogenase inhibitor 5-chloro-2,4-dihydroxypyridine)K Fujita, H Nakayama, W Ichikawa, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort studyY Nakayama, M Hashimoto, R Watanabe, et al.
Scandinavian Journal of Rheumatology|June 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort studyK Murata, T Fujii, K Ebina, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 25, 2009
Pharmacokinetics of 5-fluorouracil in elderly Japanese patients with cancer treated with S-1 (a combination of tegafur and dihydropyrimidine dehydrogenase inhibitor 5-chloro-2,4-dihydroxypyridine)K Fujita, H Nakayama, W Ichikawa, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort studyY Nakayama, M Hashimoto, R Watanabe, et al.
Scandinavian Journal of Rheumatology|June 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort studyK Murata, T Fujii, K Ebina, et al.
Pageof 8